chr11-74457469-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000310128.9(KCNE3):c.95G>A(p.Arg32Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000527 in 1,614,022 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R32W) has been classified as Likely benign.
Frequency
Consequence
ENST00000310128.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNE3 | NM_005472.5 | c.95G>A | p.Arg32Gln | missense_variant | 3/3 | ENST00000310128.9 | NP_005463.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNE3 | ENST00000310128.9 | c.95G>A | p.Arg32Gln | missense_variant | 3/3 | 1 | NM_005472.5 | ENSP00000310557 | P1 | |
ENST00000533008.1 | n.155-26708C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251252Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135786
GnomAD4 exome AF: 0.0000547 AC: 80AN: 1461808Hom.: 0 Cov.: 31 AF XY: 0.0000564 AC XY: 41AN XY: 727200
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74362
ClinVar
Submissions by phenotype
Brugada syndrome 6 Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2024 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 32 of the KCNE3 protein (p.Arg32Gln). This variant is present in population databases (rs745645715, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with KCNE3-related conditions. ClinVar contains an entry for this variant (Variation ID: 470686). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 30, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 18, 2018 | The KCNE3 c.95G>A; p.Arg32Gln variant (rs745645715), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 470686). This variant is found on seven chromosomes in the Genome Aggregation Database, indicating it is not a common polymorphism. The arginine at codon 32 is moderately conserved, but it occurs as a glutamine in several vertebrate species, and computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. Computational analyses of splicing (Alamut v.2.11) predict that this variant may create a novel cryptic acceptor splice site, but mRNA studies would be required to confirm if splicing occurs at this site. Given the lack of clinical and functional data, the significance of the p.Arg32Gln variant is uncertain at this time. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 02, 2021 | The p.R32Q variant (also known as c.95G>A), located in coding exon 1 of the KCNE3 gene, results from a G to A substitution at nucleotide position 95. The arginine at codon 32 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at